All webinar times are in Eastern Time except where noted.Convert to your time zone.
In this webinar, Dr. Fiona Ivison will provide an overview of the method development process adopted in an NHS (UK) laboratory in order to develop a DHVD assay. Dr. Ivison will describe the UKAS analytical requirements, the clinical goals her lab defined before starting the project, the order of work undertaken in the lab to meet the requirements, and the practical issues the lab had to overcome.
Please note: this webinar will be released for viewing via a playback link sent to your email on July 10, 2019 at 1:00PM ET.
What you will learn:
- How to describe the process of optimizing mass spectrometry parameters for the fragments of interest.
- How to list the analytical objectives when validating a new method.
- How to relate the analytical performance of an assay to the clinical needs.
Fiona Ivison, PhD, FRCPath
Manchester University NHS Foundation Trust Oxford, Manchester, UK